A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults

File(s)

PLOS one Tarragona-Fiol Sep 2012.pdf (766.38 KB)

Published version

Show more

Author(s)

Keefer, MC

Gilmour, J

Hayes, P

Gill, D

Kopycinski, J

more

Type

Journal Article

Date Issued

2012

Citation

PLoS One, 2012, 7, pp.e41936-

URI

http://hdl.handle.net/10044/1/10157

URL

internal-pdf://1839217646/Keefer%202012%20A%20Phase%20I%20Double%20Blind.pdf

DOI

https://www.dx.doi.org/10.1371/journal.pone.0041936

ISSN

1932-6203

Publisher

PUBLIC LIBRARY SCIENCE

Start Page

e41936

Journal / Book Title

PLoS One

Volume

7

Issue

8

Copyright Statement

© 2012 Keefer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

License URL

Attribution 4.0 International

Description

08/10/12 meb. Open access version, will pub.

Identifier

http://www.ncbi.nlm.nih.gov/pubmed/22870265

Subjects

AIDS Vaccines/*administration & dosage/genetics/immunology Adenoviruses, Human/genetics/*immunology Adolescent Adult Antibodies, Viral/blood/immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Dose-Response Relationship, Immunologic Double-Blind Method Female HIV Infections/blood/genetics/immunology/*prevention & control HIV-1/genetics/*immunology Humans Immunity, Cellular/drug effects/genetics Immunity, Humoral/drug effects/genetics Male Middle Aged Retroviridae Proteins/genetics/*immunology *Vaccination